Annovis Bio (ANVS)
Annovis Bio on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on NYSE, classified by the SEC as pharmaceutical preparations.
5.7M
Short interest
settlement 2026-10-15
8.3
Days to cover
+2.4 days vs prior
56.0%
Short share of volume
2026-11-02
18,312
Fails to deliver
settlement 2026-10-14
Thu 12 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ANVS is 5,720,877 shares, down 301,163 shares over the last month. Over the last 48 readings it ranged from 1,032,901 shares (31 October 2025) to 6,022,040 shares (15 September 2026). The latest reading sits at the top of that range. At the reported average volume of 686K shares a day that is 8.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/anvs" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 5,720,877 | -3.0% | 686,157 | 8.34 |
| 2026-09-30 | 5,895,922 | -2.1% | 990,573 | 5.95 |
| 2026-09-15 | 6,022,040 | +20.7% | 1,889,918 | 3.19 |
| 2026-08-31 | 4,989,785 | +0.5% | 520,405 | 9.59 |
| 2026-08-14 | 4,964,649 | -4.4% | 608,131 | 8.16 |
| 2026-07-31 | 5,193,076 | -4.7% | 549,684 | 9.45 |
| 2026-07-15 | 5,450,385 | +12.1% | 1,079,470 | 5.05 |
| 2026-06-30 | 4,864,454 | +1.2% | 908,320 | 5.36 |
| 2026-06-15 | 4,804,638 | -4.3% | 1,188,765 | 4.04 |
| 2026-05-29 | 5,021,073 | +7.4% | 1,602,998 | 3.13 |
| 2026-05-15 | 4,674,614 | -3.0% | 964,619 | 4.85 |
| 2026-04-30 | 4,816,770 | +1.2% | 970,735 | 4.96 |
| 2026-04-15 | 4,760,673 | +47.2% | 1,824,657 | 2.61 |
| 2026-03-31 | 3,234,406 | +16.4% | 521,946 | 6.20 |
| 2026-03-13 | 2,778,124 | +1.2% | 290,216 | 9.57 |
| 2026-02-27 | 2,745,085 | -3.1% | 376,460 | 7.29 |
| 2026-02-13 | 2,833,149 | -3.5% | 339,980 | 8.33 |
| 2026-01-30 | 2,935,736 | -6.3% | 535,090 | 5.49 |
| 2026-01-15 | 3,133,837 | +3.0% | 571,749 | 5.48 |
| 2025-12-31 | 3,044,065 | +6.5% | 459,650 | 6.62 |
| 2025-12-15 | 2,858,006 | +1.0% | 1,054,422 | 2.71 |
| 2025-11-28 | 2,829,273 | +115.2% | 7,715,624 | 1.00 |
| 2025-11-14 | 1,314,516 | +27.3% | 434,680 | 3.02 |
| 2025-10-31 | 1,032,901 | -20.4% | 695,452 | 1.49 |
| 2025-10-15 | 1,298,376 | -7.1% | 1,903,993 | 1.00 |
| 2025-09-30 | 1,398,175 | -11.9% | 207,938 | 6.72 |
| 2025-09-15 | 1,587,655 | -7.1% | 180,718 | 8.79 |
| 2025-08-29 | 1,708,692 | -8.5% | 241,541 | 7.07 |
| 2025-08-15 | 1,867,787 | -14.6% | 243,454 | 7.67 |
| 2025-07-31 | 2,187,682 | -11.1% | 328,226 | 6.67 |
| 2025-07-15 | 2,460,828 | +4.3% | 337,860 | 7.28 |
| 2025-06-30 | 2,360,022 | +7.0% | 532,840 | 4.43 |
| 2025-06-13 | 2,205,405 | +4.3% | 702,941 | 3.14 |
| 2025-05-30 | 2,113,449 | +7.8% | 516,607 | 4.09 |
| 2025-05-15 | 1,959,704 | +0.4% | 349,949 | 5.60 |
| 2025-04-30 | 1,952,592 | +11.9% | 651,427 | 3.00 |
| 2025-04-15 | 1,744,449 | -13.6% | 212,308 | 8.22 |
| 2025-03-31 | 2,019,332 | +7.5% | 291,012 | 6.94 |
| 2025-03-14 | 1,879,232 | +12.2% | 260,749 | 7.21 |
| 2025-02-28 | 1,675,108 | +16.0% | 615,257 | 2.72 |
| 2025-02-14 | 1,443,813 | -25.0% | 1,044,577 | 1.38 |
| 2025-01-31 | 1,925,112 | -10.3% | 208,591 | 9.23 |
| 2025-01-15 | 2,146,224 | +31.5% | 725,193 | 2.96 |
| 2024-12-31 | 1,632,310 | +4.5% | 311,599 | 5.24 |
| 2024-12-13 | 1,561,942 | +19.1% | 356,850 | 4.38 |
| 2024-11-29 | 1,311,926 | -5.9% | 192,293 | 6.82 |
| 2024-11-15 | 1,393,625 | -0.4% | 227,146 | 6.14 |
| 2024-10-31 | 1,399,763 | +3.0% | 361,021 | 3.88 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of ANVS volume is 56.0%, down 6.1 points over the last five sessions. Over the last 30 readings it ranged from 35.5% (27 October 2026) to 78.5% (23 September 2026). The latest reading is 5.5 points below the 30-session average of 61.5%, on 2.0M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 1.1M | 2.0M | 56.0% | 21,389 |
| 2026-10-30 | 758K | 1.0M | 73.8% | 14,933 |
| 2026-10-29 | 839K | 1.2M | 69.9% | 1,151 |
| 2026-10-28 | 407K | 674K | 60.4% | 25 |
| 2026-10-27 | 247K | 696K | 35.5% | 0 |
| 2026-10-26 | 158K | 254K | 62.1% | 1,880 |
| 2026-10-23 | 109K | 183K | 59.4% | 1,000 |
| 2026-10-22 | 186K | 284K | 65.4% | 0 |
| 2026-10-21 | 155K | 247K | 63.0% | 0 |
| 2026-10-20 | 231K | 456K | 50.5% | 30 |
| 2026-10-19 | 181K | 365K | 49.4% | 980 |
| 2026-10-16 | 200K | 326K | 61.4% | 1,802 |
| 2026-10-15 | 185K | 351K | 52.6% | 174 |
| 2026-10-14 | 207K | 440K | 47.0% | 402 |
| 2026-10-13 | 372K | 530K | 70.2% | 0 |
| 2026-10-12 | 178K | 260K | 68.4% | 0 |
| 2026-10-09 | 155K | 235K | 65.8% | 0 |
| 2026-10-08 | 180K | 322K | 55.9% | 0 |
| 2026-10-07 | 172K | 226K | 76.2% | 0 |
| 2026-10-06 | 254K | 335K | 75.9% | 300 |
| 2026-10-05 | 135K | 363K | 37.1% | 0 |
| 2026-10-02 | 230K | 348K | 66.3% | 0 |
| 2026-10-01 | 282K | 639K | 44.1% | 0 |
| 2026-09-30 | 245K | 326K | 75.1% | 3,600 |
| 2026-09-29 | 244K | 381K | 64.1% | 0 |
| 2026-09-28 | 424K | 719K | 58.9% | 2,589 |
| 2026-09-25 | 135K | 260K | 52.0% | 0 |
| 2026-09-24 | 344K | 480K | 71.8% | 0 |
| 2026-09-23 | 469K | 598K | 78.5% | 250 |
| 2026-09-22 | 456K | 586K | 77.8% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in ANVS is 18,312 shares, up 2,885 shares over the last settlement date. Over the last 30 readings it ranged from 6 shares (12 August 2026) to 33,649 shares (11 September 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 18,312 | $1.06 | $19K |
| 2026-10-13 | 15,427 | $1.15 | $18K |
| 2026-10-09 | 10,981 | $1.17 | $13K |
| 2026-10-05 | 11,943 | $1.18 | $14K |
| 2026-10-02 | 8,988 | $1.17 | $11K |
| 2026-10-01 | 13,799 | $1.27 | $18K |
| 2026-09-30 | 5,629 | $1.30 | $7K |
| 2026-09-29 | 12,817 | $1.38 | $18K |
| 2026-09-28 | 10,005 | $1.31 | $13K |
| 2026-09-25 | 9,979 | $1.33 | $13K |
| 2026-09-24 | 5,823 | $1.27 | $7K |
| 2026-09-17 | 1,021 | $1.04 | $1K |
| 2026-09-11 | 33,649 | $1.19 | $40K |
| 2026-09-10 | 3,917 | $1.22 | $5K |
| 2026-09-08 | 9,440 | $1.39 | $13K |
| 2026-09-04 | 5,470 | $1.38 | $8K |
| 2026-09-02 | 3,416 | $1.69 | $6K |
| 2026-09-01 | 13,409 | $1.72 | $23K |
| 2026-08-26 | 36 | $1.82 | $66 |
| 2026-08-20 | 12,967 | $1.85 | $24K |
| 2026-08-12 | 6 | $1.89 | $11 |
| 2026-08-07 | 68 | $1.86 | $126 |
| 2026-07-21 | 4,906 | $1.69 | $8K |
| 2026-07-07 | 528 | $1.97 | $1K |
| 2026-07-06 | 744 | $1.93 | $1K |
| 2026-07-01 | 597 | $1.86 | $1K |
| 2026-06-30 | 600 | $1.86 | $1K |
| 2026-06-26 | 13,239 | $1.65 | $22K |
| 2026-06-25 | 3,185 | $1.70 | $5K |
| 2026-06-17 | 3,337 | $1.79 | $6K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for ANVS in the last 90 days. The most recent filings are listed below. Latest filing: Hoffman Michael B (Director) on 2026-05-20.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Hoffman Michael B | Director | Buy | 55K | $1.90 | $104K | 3.4M |
| 2026-05-20 | Hoffman Michael B | Director | Buy | 19K | $1.80 | $34K | 3.3M |
| 2026-05-20 | Hoffman Michael B | Director | Buy | 3K | $1.75 | $4K | 3.3M |
| 2026-04-02 | Hoffman Michael B | Director | Buy | 714K | $2.10 | $1.5M | 3.3M |
| 2025-12-08 | Hoffman Michael B | Director | Buy | 15K | $4.24 | $64K | 2.6M |
| 2025-12-08 | Hoffman Michael B | Director | Buy | 30K | $4.34 | $130K | 2.6M |
| 2025-11-24 | Hoffman Michael B | Director | Buy | 9K | $3.85 | $35K | 2.5M |
| 2025-11-24 | Hoffman Michael B | Director | Buy | 415 | $4.14 | $2K | 2.5M |
| 2025-11-24 | Hoffman Michael B | Director | Buy | 28K | $4.15 | $117K | 2.5M |
| 2025-11-24 | Hoffman Michael B | Director | Buy | 1K | $4.13 | $6K | 2.5M |
| 2025-11-24 | Hoffman Michael B | Director | Buy | 28K | $4.15 | $117K | 2.5M |
| 2025-11-24 | Hoffman Michael B | Director | Buy | 415 | $4.14 | $2K | 2.5M |
| 2025-11-24 | Hoffman Michael B | Director | Buy | 9K | $3.85 | $35K | 2.5M |
| 2025-11-24 | Hoffman Michael B | Director | Buy | 1K | $4.13 | $6K | 2.5M |
| 2025-11-21 | Hoffman Michael B | Director | Buy | 10K | $3.50 | $35K | 2.5M |
| 2025-11-21 | Hoffman Michael B | Director | Buy | 10K | $3.49 | $35K | 2.5M |
| 2025-11-14 | Hoffman Michael B | Director | Buy | 15K | $2.11 | $32K | 2.5M |
| 2025-10-28 | Maccecchini Maria-Luisa | President & CEO | Buy | 98K | $2.05 | $200K | 1.2M |
| 2025-10-28 | Hoffman Michael B | Director | Buy | 976K | $2.05 | $2.0M | 2.5M |
| 2025-09-10 | Bruck Claudine | Director | Exercise or conversion | 7K | $0.14 | $1000 | 14K |
| 2025-08-29 | Hoffman Michael B | Director | Grant | 5K | $2.30 | $12K | 1.5M |
| 2025-08-29 | Hoffman Michael B | Director | Grant | 5K | $2.29 | $11K | 1.5M |
| 2025-08-29 | Hoffman Michael B | Director | Grant | 5K | $2.28 | $11K | 1.5M |
| 2025-08-19 | Hoffman Michael B | Director | Grant | 1K | $2.57 | $3K | 1.5M |
| 2025-08-19 | Hoffman Michael B | Director | Grant | 6K | $2.58 | $14K | 1.5M |
| 2025-08-19 | Hoffman Michael B | Director | Grant | 5K | $2.59 | $14K | 1.5M |
| 2025-08-19 | Hoffman Michael B | Director | Grant | 7K | $2.60 | $17K | 1.5M |
| 2025-06-16 | Walsh Andrew | Vice President, Finance | Grant | 500 | $2.90 | $1K | 500 |
| 2025-06-13 | Hoffman Michael B | Director | Grant | 1 | $2.83 | $3 | 1.4M |
| 2025-06-13 | Hoffman Michael B | Director | Grant | 25K | $2.80 | $70K | 1.4M |
| 2025-06-10 | McCarthy Reid | Director | Grant | 2K | $2.95 | $6K | 9K |
| 2025-06-04 | Maccecchini Maria-Luisa | President & CEO | Grant | 46K | $3.37 | $155K | 1.1M |
| 2025-05-29 | Hoffman Michael B | Director | Grant | 5K | $2.43 | $12K | 1.4M |
| 2024-03-31 | Maccecchini Maria-Luisa | President and CEO | Gift | 10K | $0.00 | $0 | 1.1M |
| 2024-03-31 | Maccecchini Maria-Luisa | President and CEO | Gift | 10K | $0.00 | $0 | 1.1M |
| 2024-03-28 | Maccecchini Maria-Luisa | President and CEO | Gift | 10K | $0.00 | $0 | 1.1M |
| 2023-11-20 | Bruck Claudine | Director | Grant | 1K | $6.07 | $6K | 8K |
| 2023-11-20 | Hagopian Henry III | Chief Financial Officer | Grant | 824 | $6.07 | $5K | 2K |
| 2023-11-20 | Maccecchini Maria-Luisa | President and CEO | Grant | 41K | $6.07 | $250K | 1.1M |
| 2023-11-20 | White Mark K. | Director | Grant | 2K | $6.07 | $12K | 61K |
| 2023-11-20 | Hoffman Michael B | Director,TenPercentOwner | Grant | 165K | $6.07 | $1.0M | 224K |
| 2023-11-20 | McCarthy Reid | Director | Grant | 824 | $6.07 | $5K | 8K |
| 2023-11-20 | Bruck Claudine | Director | Other transaction | 0 | $0.00 | $0 | 7K |
| 2023-11-20 | Hagopian Henry III | Chief Financial Officer | Grant | 820 | $6.10 | $5K | 2K |
| 2023-11-20 | Maccecchini Maria-Luisa | President and CEO | Grant | 41K | $6.10 | $250K | 1.1M |
| 2023-11-20 | Hoffman Michael B | Director,TenPercentOwner | Grant | 164K | $6.10 | $1000K | 223K |
| 2023-11-20 | McCarthy Reid | Director | Other transaction | 0 | $0.00 | $0 | 7K |
| 2023-11-20 | White Mark K. | Director | Grant | 2K | $6.10 | $12K | 61K |
| 2023-04-24 | Maccecchini Maria-Luisa | President and CEO | Gift | 3K | $0.00 | $0 | 1.1M |
| 2023-04-07 | Maccecchini Maria-Luisa | President and CEO | Grant | 20K | $12.61 | $252K | 1.1M |
| 2023-04-07 | McCarthy Reid | Director | Grant | 476 | $12.61 | $6K | 7K |
| 2023-04-07 | Hoffman Michael B | Director,TenPercentOwner | Grant | 59K | $12.61 | $750K | 59K |
| 2023-04-07 | Hagopian Henry III | Chief Financial Officer | Grant | 1K | $12.61 | $13K | 1K |
| 2023-04-07 | Bruck Claudine | Director | Grant | 500 | $12.61 | $6K | 7K |
| 2023-04-07 | White Mark K. | Director | Grant | 3K | $12.61 | $38K | 59K |
| 2023-02-06 | Maccecchini Maria-Luisa | President and CEO | Exercise or conversion | 53K | $0.14 | $7K | 1.0M |
| 2022-01-14 | Maccecchini Maria-Luisa | President and CEO | Exercise or conversion | 33K | $0.14 | $5K | 988K |
| 2022-01-04 | Hoffman Michael B | Director,TenPercentOwner | Exercise or conversion | 30K | $4.39 | $132K | 1.4M |
| 2022-01-04 | Hoffman Michael B | Director,TenPercentOwner | Tax withholding | 7K | $19.78 | $132K | 1.4M |
| 2022-01-04 | Hoffman Michael B | Director,TenPercentOwner | Exercise or conversion | 7K | $0.25 | $2K | 1.4M |
| 2022-01-04 | Hoffman Michael B | Director,TenPercentOwner | Tax withholding | 90 | $19.78 | $2K | 1.4M |
| 2021-10-12 | White Mark K. | Director | Buy | 5K | $27.40 | $137K | 56K |
| 2021-10-11 | Maccecchini Maria-Luisa | PRESIDENT AND CEO | Buy | 18K | $27.61 | $497K | 977K |
| 2021-10-11 | Bruck Claudine | Director | Buy | 181 | $27.66 | $5K | 6K |
| 2021-08-19 | McCarthy Reid | Director | Buy | 500 | $37.61 | $19K | 7K |
| 2020-02-03 | McGroarty Jeffrey Brian | Chief Financial Officer | Buy | 19K | $7.15 | $138K | 53K |
| 2020-02-03 | McGroarty Jeffrey Brian | Chief Financial Officer | Buy | 164 | $7.17 | $1K | 53K |
| 2020-01-31 | White Mark K. | Director | Conversion | 12K | price not stated in the filing | not stated | 13K |
| 2020-01-31 | White Mark K. | Director | Buy | 2K | $6.00 | $10K | 2K |
| 2020-01-31 | White Mark K. | Director | Conversion | 35K | price not stated in the filing | not stated | 48K |
| 2020-01-31 | White Mark K. | Director | Conversion | 3K | $4.80 | $16K | 51K |
| 2020-01-31 | McGroarty Jeffrey Brian | Chief Financial Officer | Buy | 33K | $6.00 | $200K | 33K |
| 2020-01-31 | Maccecchini Maria-Luisa | President and CEO | Conversion | 8K | price not stated in the filing | not stated | 216K |
| 2020-01-31 | Maccecchini Maria-Luisa | President and CEO | Buy | 2K | $6.00 | $10K | 208K |
| 2020-01-31 | Maccecchini Maria-Luisa | President and CEO | Conversion | 763K | price not stated in the filing | not stated | 979K |
| 2020-01-31 | Bruck Claudine | Director | Conversion | 4K | price not stated in the filing | not stated | 5K |
| 2020-01-31 | Bruck Claudine | Director | Conversion | 1K | $4.80 | $5K | 6K |
| 2020-01-31 | Bruck Claudine | Director | Buy | 800 | $6.00 | $5K | 800 |
| 2020-01-31 | Whelan, Jr. Robert M. | Director | Conversion | 11K | $4.80 | $54K | 96K |
| 2020-01-31 | Whelan, Jr. Robert M. | Director | Conversion | 60K | price not stated in the filing | not stated | 85K |
| 2020-01-31 | Whelan, Jr. Robert M. | Director | Buy | 25K | $6.00 | $150K | 25K |
| 2020-01-31 | Hoffman Michael B | Director,TenPercentOwner | Buy | 33K | $6.00 | $200K | 48K |
| 2020-01-31 | Hoffman Michael B | Director,TenPercentOwner | Conversion | 159K | price not stated in the filing | not stated | 206K |
| 2020-01-31 | Hoffman Michael B | Director,TenPercentOwner | Conversion | 1.1M | price not stated in the filing | not stated | 1.3M |
| 2020-01-31 | Hoffman Michael B | Director,TenPercentOwner | Conversion | 56K | $4.80 | $268K | 1.4M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for ANVS worth $15K at the prices reported; 0 in the last 90 days worth $0. Latest: White Mark K. filed on 2026-04-02 to sell 7,142 shares ($15K) from 2026-04-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-04-02 | White Mark K.Director | 7K | $15K | 0.025% | 2026-04-02 | Stifel Nicolaus & Company Inc |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of ANVS in its latest filing, on Schedule 13G (passive). The holder is Highbridge Capital Management, LLC at 6.1% of the class (2,775,578 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-15 | 13G/Ano. 1 | Ryan M. Laneparent holding company, individual | 2.2M | 5.0% | 2026-09-30 |
| 2026-10-15 | 13G/Ano. 1 | Empery Asset Management, LPinvestment adviser, partnership | 2.2M | 5.0% | 2026-09-30 |
| 2026-08-14 | 13G | Highbridge Capital Management, LLCinvestment adviser, other entity | 2.8M | 6.1% | 2026-06-30 |
13F holders
Tracked managers holding ANVS at their latest 13F. JSON4 of the 30 tracked managers held ANVS at their latest 13F, $3.4M in total at quarter-end prices. Renaissance Technologies is the largest at $1.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 1.0M | $1.9M | 0.00% | +655K |
| Two Sigma Investments | 2026-06-30 | 580K | $1.1M | 0.00% | -48K |
| Citadel Advisors | 2026-06-30 | 244K | $453K | 0.00% | new |
| Millennium Management | 2026-06-30 | 23K | $44K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Annovis Bio in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Annovis Bio (ANVS), SEC CIK 1477845, listed on NYSE, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-04-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-15.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-05-20.JSON and CSV
- Company record
- EDGAR filing index for CIK 1477845Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of ANVS is sold short?
5,720,877 shares were held short at the 2026-10-15 settlement, 8.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ANVS's daily short volume?
On 2026-11-02, 1,123,871 of the 2,007,893 ANVS shares reported to FINRA were sold short, 56.0% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ANVS have fails to deliver?
The SEC's latest file shows 18,312 ANVS shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are ANVS insiders buying or selling?
No open-market insider trades were reported for ANVS in the last 90 days. The most recent filings are listed below. Latest filing: Hoffman Michael B (Director) on 2026-05-20.
Have ANVS insiders filed to sell?
1 Form 144 notice on file for ANVS worth $15K at the prices reported; 0 in the last 90 days worth $0. Latest: White Mark K. filed on 2026-04-02 to sell 7,142 shares ($15K) from 2026-04-02.
Who owns 5% or more of ANVS?
1 holder reports 5% or more of ANVS in its latest filing, on Schedule 13G (passive). The holder is Highbridge Capital Management, LLC at 6.1% of the class (2,775,578 shares), filed 2026-08-14 for an event on 2026-06-30.
Which tracked 13F managers own ANVS?
4 of the 30 tracked 13F managers held ANVS shares at their latest filing, $3.4M in all. The largest: Renaissance Technologies (1.0M shares, $1.9M), Two Sigma Investments (580K shares, $1.1M), Ken Griffin's Citadel Advisors (244K shares, $453K), Izzy Englander's Millennium Management (23K shares, $44K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.